Evidence map›Paper›PMID 40263570›Full record

ArticleScientific reports2025

Publisher Correction: Impaired MC3T3-E1 osteoblast differentiation triggered by oncogenic HRAS is rescued by the farnesyltransferase inhibitor Tipifarnib.

Yannik Andrasch, Moses Munene Ireri, Jonas Gander, Ann-Engelke Sabrina Timm, Saravanakkumar Chennappan, Miray Fidan, Melanie Engler, Ion Cristian Cirstea

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yannik AndraschInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Moses Munene Ireri *Institute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Jonas Gander *Institute of Applied Physiology, Ulm University, Ulm, Germany.
Ann-Engelke Sabrina TimmInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Saravanakkumar ChennappanMasonic Medical Research Institute, Utica, NY, USA.
Miray FidanInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Melanie EnglerInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany.
Ion Cristian CirsteaInstitute of Comparative Molecular Endocrinology, Ulm University, Ulm, Germany. ion.cirstea@uni-ulm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40263570
PMCPMC12015491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.